Peter A S Johnstone1,2, Susan Peneguy1, Timothy N Showalter3, James B Yu4. 1. Department of Radiation Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL, United States. 2. Department of Heath Outcomes & Behavior, Moffitt Cancer Center & Research Institute, Tampa, FL, United States. 3. University of Virginia, Charlottesville, VA, United States. 4. Yale Cancer Center, New Haven, CT, United States.
Abstract
AIM: Describe the Value proposition for radiotherapy (RT) in the United States. BACKGROUND: In the United States since 2005, two forces have worked to decrease RT cost per patient: Federal changes in reimbursement and hypofractionation of treatment courses. We theorize that these have driven stable reimbursement in the context of increasing technology of intensity modulation (IMRT) and image guidance (IGRT). This phenomenon provides increasing Value of the discipline to patients and systems. MATERIALS AND METHODS: We searched the Medicare Physician/Supplier data for Program Payments per Person with Utilization for 2000 through 2016. This involves two databases: Enrollment Database (EDB) for 2000-2012 and Common Medicare Enrollment (CME) since 2013. RT payments to individual patients accessing services were retrieved. RESULTS: Taking into account the change of calculation algorithm used by CMS in 2013, costs per patient were similar in 2012 and 2003, and 2016 and 2013. CONCLUSIONS: In the United States, stabilizing costs in the face of increasing work, better outcomes, and decreased toxicity contributes to increasing RT value over the past 10 years.
AIM: Describe the Value proposition for radiotherapy (RT) in the United States. BACKGROUND: In the United States since 2005, two forces have worked to decrease RT cost per patient: Federal changes in reimbursement and hypofractionation of treatment courses. We theorize that these have driven stable reimbursement in the context of increasing technology of intensity modulation (IMRT) and image guidance (IGRT). This phenomenon provides increasing Value of the discipline to patients and systems. MATERIALS AND METHODS: We searched the Medicare Physician/Supplier data for Program Payments per Person with Utilization for 2000 through 2016. This involves two databases: Enrollment Database (EDB) for 2000-2012 and Common Medicare Enrollment (CME) since 2013. RT payments to individual patients accessing services were retrieved. RESULTS: Taking into account the change of calculation algorithm used by CMS in 2013, costs per patient were similar in 2012 and 2003, and 2016 and 2013. CONCLUSIONS: In the United States, stabilizing costs in the face of increasing work, better outcomes, and decreased toxicity contributes to increasing RT value over the past 10 years.
Entities:
Keywords:
Health services research; Radiation oncology; Value
Authors: David J Hoopes; David Kaziska; Patrick Chapin; Daniel Weed; Benjamin D Smith; E Ronald Hale; Peter A Johnstone Journal: Int J Radiat Oncol Biol Phys Date: 2011-01-27 Impact factor: 7.038
Authors: Stephen Lutz; Lawrence Berk; Eric Chang; Edward Chow; Carol Hahn; Peter Hoskin; David Howell; Andre Konski; Lisa Kachnic; Simon Lo; Arjun Sahgal; Larry Silverman; Charles von Gunten; Ehud Mendel; Andrew Vassil; Deborah Watkins Bruner; William Hartsell Journal: Int J Radiat Oncol Biol Phys Date: 2011-01-27 Impact factor: 7.038
Authors: Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy Journal: JAMA Date: 2010-03-17 Impact factor: 56.272
Authors: Elyn H Wang; Sarah S Mougalian; Pamela R Soulos; Charles E Rutter; Suzanne B Evans; Bruce G Haffty; Cary P Gross; James B Yu Journal: Int J Radiat Oncol Biol Phys Date: 2014-08-19 Impact factor: 7.038
Authors: Sushil Beriwal; Malolan S Rajagopalan; John C Flickinger; Susan M Rakfal; Edwin Rodgers; Dwight E Heron Journal: Int J Radiat Oncol Biol Phys Date: 2012-01-13 Impact factor: 7.038
Authors: Kyle E Rusthoven; Brian D Kavanagh; Stuart H Burri; Changhu Chen; Higinia Cardenes; Mark A Chidel; Thomas J Pugh; Madeleine Kane; Laurie E Gaspar; Tracey E Schefter Journal: J Clin Oncol Date: 2009-03-02 Impact factor: 44.544
Authors: Kyle E Rusthoven; Brian D Kavanagh; Higinia Cardenes; Volker W Stieber; Stuart H Burri; Steven J Feigenberg; Mark A Chidel; Thomas J Pugh; Wilbur Franklin; Madeleine Kane; Laurie E Gaspar; Tracey E Schefter Journal: J Clin Oncol Date: 2009-03-02 Impact factor: 44.544
Authors: Ya-Chen Tina Shih; Ying Xu; Cathy Bradley; Sharon H Giordano; James Yao; K Robin Yabroff Journal: J Natl Cancer Inst Date: 2022-10-06 Impact factor: 11.816